Beyond estimates: optimizing surgical strategies through accurate blood loss measurement.
作者信息
Furlanetto Alessandro, Marchini Andrea, Nieddu Eleonora, Lanari Jacopo, D'Amico Francesco Enrico, Vitale Alessandro, Feltracco Paolo, Gringeri Enrico, Cillo Umberto
机构信息
Hepato-bilio-pancreatic Surgery and Liver Transplantation Unit, Padova University Hospital, Padova, Italy.
Anesthesiology and Intensive Care Unit, Department of Medicine (DIMED), Padua University Hospital, Padua, Italy.
出版信息
Hepatobiliary Surg Nutr. 2025 Jun 1;14(3):464-466. doi: 10.21037/hbsn-2025-75. Epub 2025 May 26.
Abstract
摘要
相似文献
1
Beyond estimates: optimizing surgical strategies through accurate blood loss measurement.超越估计：通过精确测量失血量优化手术策略。
Hepatobiliary Surg Nutr. 2025 Jun 1;14(3):464-466. doi: 10.21037/hbsn-2025-75. Epub 2025 May 26.
2
The prognostic role of in-hospital transfusion of fresh frozen plasma in patients with cholangiocarcinoma undergoing curative-intent liver surgery.新鲜冰冻血浆院内输血在接受根治性肝手术的胆管癌患者中的预后作用
Eur J Surg Oncol. 2022 Mar;48(3):604-614. doi: 10.1016/j.ejso.2021.09.011. Epub 2021 Sep 20.
3
Immunotherapy of cholangiocarcinoma: Therapeutic strategies and predictive biomarkers.胆管癌的免疫治疗：治疗策略和预测生物标志物。
Cancer Lett. 2022 Oct 10;546:215853. doi: 10.1016/j.canlet.2022.215853. Epub 2022 Jul 31.
4
Survival of Patients with Cholangiocarcinoma Receiving Surgical Treatment in an O. viverrini Endemic Area in Thailand: A Retrospective Cohort Study.在泰国华支睾吸虫流行区接受手术治疗的胆管癌患者的生存情况：一项回顾性队列研究。
Asian Pac J Cancer Prev. 2020 Apr 1;21(4):903-909. doi: 10.31557/APJCP.2020.21.4.903.
5
FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targeted.FOSL1 通过可作为治疗靶点的转录效应因子促进胆管癌的发生。
J Hepatol. 2021 Aug;75(2):363-376. doi: 10.1016/j.jhep.2021.03.028. Epub 2021 Apr 20.
6
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease.意大利胆管癌：一项关于临床特征、诊断方式和治疗的全国性调查。结果来自意大利肝病研究协会的“胆管癌”委员会。
Dig Liver Dis. 2011 Jan;43(1):60-5. doi: 10.1016/j.dld.2010.05.002. Epub 2010 Jun 26.
7
HDAC6-dependent ciliophagy is involved in ciliary loss and cholangiocarcinoma growth in human cells and murine models.组蛋白去乙酰化酶 6 依赖性纤毛ophagy 参与人细胞和小鼠模型中的纤毛丢失和胆管癌生长。
Am J Physiol Gastrointest Liver Physiol. 2020 Jun 1;318(6):G1022-G1033. doi: 10.1152/ajpgi.00033.2020. Epub 2020 Apr 27.
8
Predictive Factors for Post-Hepatectomy Liver Failure in Patients with Cholangiocarcinoma.预测胆管癌患者肝切除术后肝功能衰竭的因素。
Asian Pac J Cancer Prev. 2023 Feb 1;24(2):575-580. doi: 10.31557/APJCP.2023.24.2.575.
9
Preoperative Biliary Drainage Is Associated with Increased Complications After Liver Resection for Proximal Cholangiocarcinoma.术前胆道引流与近端胆管癌肝切除术后并发症增加相关。
J Gastrointest Surg. 2018 Nov;22(11):1950-1957. doi: 10.1007/s11605-018-3861-3. Epub 2018 Jul 6.
10
Current Surgical Management of Peri-Hilar and Intra-Hepatic Cholangiocarcinoma.肝门周围及肝内胆管癌的当前外科治疗
Cancers (Basel). 2021 Jul 21;13(15):3657. doi: 10.3390/cancers13153657.
本文引用的文献
1
Comparison of the outcomes between ultrasonic devices and clamping in hepatectomy: a meta-analysis.超声设备与夹闭在肝切除术中效果的比较：荟萃分析。
World J Surg Oncol. 2024 Nov 16;22(1):304. doi: 10.1186/s12957-024-03575-3.
2
Estimation of intraoperative blood loss in hepatopancreatobiliary surgery: a Delphi consensus process of the European-African Hepato-Pancreato-Biliary Association (E-AHPBA).肝胰胆外科手术中术中失血量的评估：欧洲-非洲肝胰胆协会（E-AHPBA）的德尔菲共识过程
Br J Surg. 2024 Oct 1;111(10). doi: 10.1093/bjs/znae256.
3
Comment on "The Goal of Intraoperative Blood Loss in Major Hepatectomy Resection for Perihilar Cholangiocarcinoma Saving Patients From a Heavy Complication Burden".对《肝门部胆管癌扩大肝切除术中控制失血的目标：减轻患者严重并发症负担》的评论
Ann Surg Open. 2024 Jan 8;5(1):e371. doi: 10.1097/AS9.0000000000000371. eCollection 2024 Mar.
4
Recommendations on Robotic Hepato-Pancreato-Biliary Surgery. The Paris Jury-Based Consensus Conference.机器人肝胆胰外科手术推荐意见。基于巴黎评审团的共识会议
Ann Surg. 2025 Jan 1;281(1):136-153. doi: 10.1097/SLA.0000000000006365. Epub 2024 May 24.
5
Clinical Outcomes of Robotic Resection for Perihilar Cholangiocarcinoma: A First, Multicenter, Trans-Atlantic, Expert-Center, Collaborative Study.机器人辅助肝门部胆管癌切除术的临床疗效：首次多中心、跨大西洋、专家中心协作研究。
Ann Surg Oncol. 2024 Jan;31(1):81-89. doi: 10.1245/s10434-023-14307-4. Epub 2023 Sep 18.
6
Accurate resection of hilar cholangiocarcinoma using eOrganmap 3D reconstruction and full quantization technique.使用eOrganmap 3D重建和全量化技术精确切除肝门部胆管癌。
World J Gastrointest Surg. 2023 Aug 27;15(8):1693-1702. doi: 10.4240/wjgs.v15.i8.1693.
7
Minimally Invasive Surgery for Perihilar Cholangiocarcinoma: A Systematic Review of the Short- and Long-Term Results.肝门部胆管癌的微创手术：短期和长期结果的系统评价
Cancers (Basel). 2023 Jun 3;15(11):3048. doi: 10.3390/cancers15113048.
8
The Goal of Intraoperative Blood Loss in Major Hepatobiliary Resection for Perihilar Cholangiocarcinoma: Saving Patients From a Heavy Complication Burden.肝门部胆管癌根治性切除术中出血的目标：避免严重并发症，拯救患者。
Ann Surg. 2023 Nov 1;278(5):e1035-e1040. doi: 10.1097/SLA.0000000000005869. Epub 2023 Apr 13.
9
Intraoperative Blood Loss Estimation in Hepato-pancreato-biliary Surgery- Relevant, Not Reported, Not Standardized: Results From a Systematic Review and a Worldwide Snapshot Survey.肝胰胆外科手术中的术中出血量估计——相关但未报告，也未标准化：系统评价和全球快照调查结果。
Ann Surg. 2023 Apr 1;277(4):e849-e855. doi: 10.1097/SLA.0000000000005536. Epub 2022 Jul 15.
10
Application of controlled low central venous pressure during hepatectomy: A systematic review and meta-analysis.肝切除术中应用控制性低中心静脉压：系统评价和荟萃分析。
J Clin Anesth. 2021 Dec;75:110467. doi: 10.1016/j.jclinane.2021.110467. Epub 2021 Aug 1.
Zotero 插件